Vectorized was founded on the premise that the existing tools were too complex and not designed for today’s streaming requirements. Today the company released its first product, ...

AMSTERDAM--(BUSINESS WIRE)--VectorY, a fully integrated gene therapy company focused on the development of innovative vectorized antibodies for muscular and neurodegenerative disorders, today ...

Title: ETX201: An experimental vectorized miRNA-based approach for the treatment of Angelman syndrome Presenter: Sirika Pillay, Ph.D., Director of Molecular and Cellular Pharmacology, Encoded ...

VectorY is using an AAV5 variant to target the roughly 500,000 motor neurons in humans, a small slice of the 100 billion or so total neurons. The vectorized antibody treatment is administered into ...